SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
By Antoine Daina, Olivier Michielin, Vincent Zoete. Scientific Reports, 2017
7,392 citations recorded by the source corpus.
To be effective as a drug, a potent molecule must reach its target in the body in sufficient concentration, and stay there in a bioactive form long enough for the expected biologic events to occur. Drug development involves assessment of absorption, distribution, metabolism and excretion (ADME) increasingly earlier in the discovery process, at a stage when considered compounds are numerous but access to the physical samples is limited. In that context, computer models constitute valid alternatives to experiments. Here, we present the new SwissADME web tool that gives free access to a pool of fast yet robust predictive models for physicochemical properties, pharmacokinetics, drug-likeness and medicinal chemistry friendliness, among which in-house proficient methods such as the BOILED-Egg, iLOGP and Bioavailability Radar. Easy efficient input and interpretation are ensured thanks to a user-friendly interface through the login-free website http://www.swissadme.ch. Specialists, but also nonexpert in cheminformatics or computational chemistry can predict rapidly key parameters for a collection of molecules to support their drug discovery endeavours.
Subfields: Computational Theory and Mathematics, Pharmacology, Spectroscopy
View Paper: https://www.semanticscholar.org/paper/9fce7e2e705ebb141121df885767b1de4e699367
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Computational Theory and Mathematics
Citations in the corpus
- Computational Approaches in Preclinical Studies on Drug Discovery and Development (2020, neutral): “SwissADME also supplies a link for the one-click submission of the queried molecules to other servers in the Swiss series for further analysis (Daina et al., 2017).”
- In silico methods and tools for drug discovery (2021, neutral): “These models include PreADMET [213], ALOGPS [214], SwissADME [215], and DrugMint [216].”
- SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules (2019, neutral): “The ‘twins’ icon sub-mits the molecule to SwissSimilarity (21) for ligand-based direct screening, the ‘target’ for re-submitting the target prediction (on another species, for instance) and the ‘pill’ icon to estimate physicochemical, ADME or pharmacokinetic parameters by SwissADME (20).”
- SwissDock 2024: major enhancements for small-molecule docking with Attracting Cavities and AutoDock Vina (2024, neutral): “With a simple click, it is possible for instance to retrieve ADME parameters of a ligand through SwissADME ( 31 ), similar small molecules through SwissSimilarity ( 22 ), and possible targets through SwissTargetPrediction ( 30 ).”
- ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database (2018, neutral): “SwissADME [45] Free Yes Number: 19 Contents: B, A, D, M No Yes No Yes No”
- ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support (2024, neutral): “Representative tools include admet-SAR ( 5 ), SwissADME ( 6 ) and ProTox-II ( 7 ), as well as several web-based platforms developed after the release of AD-METlab 2.0 ( 8 ), such as ADMETboost ( 9 ) and Interpretable-ADMET ( 10 ).”
- Discovery of a structural class of antibiotics with explainable deep learning (2023, positive): “The medicinal chemistry property predictions shown in Supplementary Table 3 were performed using SwissADME 52 .”
- Artificial intelligence to deep learning: machine intelligence approach for drug discovery (2021, positive): “Recently, a freely accessible, user-friendly graphical interface SwissADME (http:// www. swiss adme. ch) was developed to evaluate the compatibility of the drug and its pharmacokinetic actions [145].”